Registration for Confidential Meeting Access

Breakthrough in Narcolepsy: Unveiling Preclinical Results on Dual Orexin Receptor Agonists

This exclusive presentation by Aexon Labs unveils preclinical results on novel dual orexin receptor agonists, AEX-2 and AEX-41. This scientific update bridges historical insights on narcolepsy pathophysiology with cutting-edge pharmacological strategies aimed at restoring orexin signaling and reducing cataplexy. Discover how decades of research are converging into a new therapeutic frontier.
To access this confidential video, please complete the form below. Upon validation, you will receive a password granting unlimited access to the meeting starting May 30, 2025. By submitting this form, you agree not to share, distribute, or reproduce the video without prior written consent from Aexon Labs.